Rula Hajj-Ali (@rulahajjalimd) 's Twitter Profile
Rula Hajj-Ali

@rulahajjalimd

Professor of Medicine. Vice Chair Rheumatology. Vasculitis Center, Associate Director. Cleveland Clinic. Special Needs advocate . Views and opinions are my own.

ID: 1044578454002429952

calendar_today25-09-2018 13:24:45

244 Tweet

703 Followers

398 Following

Rula Hajj-Ali (@rulahajjalimd) 's Twitter Profile Photo

Dr Peter Merkel presents data on Vilobelimab, a monoclonal Ab for C5a in AAV. Vilobelimab has the potential to 1-induce remission along with the use of RTX or CYC with no steroids 2-reduce GC toxicity #IXchange trial ⁦Vasculitis 2022⁩⁦Vasculitis Foundation

Dr Peter Merkel presents data on Vilobelimab, a monoclonal Ab for C5a in AAV. Vilobelimab has the potential to 1-induce remission along with the use of RTX or CYC with no steroids 2-reduce GC toxicity #IXchange trial ⁦<a href="/Vasculitis2022/">Vasculitis 2022</a>⁩⁦<a href="/VasculitisFound/">Vasculitis Foundation</a>⁩
Rula Hajj-Ali (@rulahajjalimd) 's Twitter Profile Photo

Thank you Dr Fussner for deep dive into Pexivas data on DAH. Plasmapheresis did not change mortality in patients with or without DAH or by severity of DAH.Lynn Fussner Vasculitis 2022

Leonard Calabrese (@lcalabresedo) 's Twitter Profile Photo

Rula ⁦Rula Hajj-Ali⁩ presents the VCRC plan that will revolutionize and transform the field of CNS vasculitis!! #ACR22. Methodically One patient at a time!!! ⁦Cassandra Calabrese⁩ ⁦Mike Putman⁩ ⁦Anisha Dua⁩ ⁦Peter Grayson⁩ ⁦KenWarringtonMD⁩ ⁦

Rula ⁦<a href="/RulaHajjAliMD/">Rula Hajj-Ali</a>⁩ presents the VCRC plan that will revolutionize and transform the field of CNS vasculitis!! #ACR22.  Methodically One patient at a time!!! ⁦<a href="/CCalabreseDO/">Cassandra Calabrese</a>⁩ ⁦<a href="/EBRheum/">Mike Putman</a>⁩ ⁦<a href="/anisha_dua/">Anisha Dua</a>⁩ ⁦<a href="/petercgrayson/">Peter Grayson</a>⁩ ⁦<a href="/MdWarrington/">KenWarringtonMD</a>⁩ ⁦
Rula Hajj-Ali (@rulahajjalimd) 's Twitter Profile Photo

This work will not not be successful without the support of Len Calabrese Leonard Calabrese. Thank you Len for all your work and support in this domain 🙏

Rula Hajj-Ali (@rulahajjalimd) 's Twitter Profile Photo

Vilobelimab , C5 a inhibitor , in phase 2 trial induced remission together with RTX or CYC with substantial reduction in the dose and toxicity of GC. One arm with no GC!! ⁦Vasculitis Foundation⁩ ⁦Kevin Byram, MD⁩ ⁦KenWarringtonMD⁩ ⁦Anisha Dua

Vilobelimab , C5 a inhibitor , in phase 2 trial induced remission together with RTX or CYC with substantial reduction in the dose and toxicity of GC. One arm with no GC!! ⁦<a href="/VasculitisFound/">Vasculitis Foundation</a>⁩ ⁦<a href="/kwbyram/">Kevin Byram, MD</a>⁩ ⁦<a href="/MdWarrington/">KenWarringtonMD</a>⁩ ⁦<a href="/anisha_dua/">Anisha Dua</a>⁩
Rula Hajj-Ali (@rulahajjalimd) 's Twitter Profile Photo

Check out our data by Dr Vural Adil F Vural, MD comparing efficacy and safety when switching from RTX to RTX-pvvr in maintenance therapy in GPA. 98% of pts remained in rem with = infect and infusion rx,PROMIS ⁦Vasculitis Foundation⁩ ⁦⁦Mike Putman⁩ ⁦⁦KenWarringtonMD

Check out our data by Dr Vural <a href="/adil_fethi/">Adil F Vural, MD</a> comparing efficacy and safety when switching from RTX to RTX-pvvr in maintenance therapy in GPA. 98% of pts remained in rem with = infect and infusion rx,PROMIS ⁦<a href="/VasculitisFound/">Vasculitis Foundation</a>⁩ ⁦⁦<a href="/EBRheum/">Mike Putman</a>⁩ ⁦⁦<a href="/MdWarrington/">KenWarringtonMD</a>⁩
Adel Hajj Ali (@adel_hajj_ali) 's Twitter Profile Photo

Excited to announce my match at Indiana University for Internal Medicine Residency #Match2023! Very thankful for the opportunity and forever grateful for the support of my family, friends and mentors Indiana University Internal Medicine Inside The Match The Internal Med Applicant ☤ IMG_stories Advocates for IMGs

Excited to announce my match at Indiana University for Internal Medicine Residency #Match2023! Very thankful for the opportunity and forever grateful for the support of my family, friends and mentors  <a href="/IUIntMed/">Indiana University Internal Medicine</a> <a href="/Inside_TheMatch/">Inside The Match</a> <a href="/InternalMed_Res/">The Internal Med Applicant ☤</a> <a href="/StoriesImg/">IMG_stories</a> <a href="/IMG_Advocate/">Advocates for IMGs</a>
Rula Hajj-Ali (@rulahajjalimd) 's Twitter Profile Photo

Check out our poster on the largest cohort of Susac s/o to date!! presented by The Adam Brown. Rituximab has a role in this disease ⁦Adam J Brown⁩ #ACR23 ⁦Cleveland Clinic MD⁩⁦Emily Littlejohn

Check out our poster on the largest cohort of Susac s/o to date!! presented by The Adam Brown. Rituximab has a role in this disease ⁦<a href="/AdamJBrownMD/">Adam J Brown</a>⁩ #ACR23 ⁦<a href="/CleClinicMD/">Cleveland Clinic MD</a>⁩⁦<a href="/ELittlejohnDO/">Emily Littlejohn</a>⁩
Rula Hajj-Ali (@rulahajjalimd) 's Twitter Profile Photo

Check out our poster on non infectious uveitis by Dr Koenig. Posterior and intermediate uveitis location is associated with longest duration of therapy. The earlier Rx with IS the shorter the duration of treatment.#ACR23⁦⁦Cleveland Clinic MD⁩⁦Taylor Koenig

Check out our poster on non infectious uveitis  by Dr Koenig. Posterior and intermediate uveitis location is associated with longest duration of therapy. The earlier Rx with IS the shorter the duration of treatment.#ACR23⁦⁦<a href="/CleClinicMD/">Cleveland Clinic MD</a>⁩⁦<a href="/tay_lorkoenig/">Taylor Koenig</a>⁩
Rula Hajj-Ali (@rulahajjalimd) 's Twitter Profile Photo

Pregnancies with vasculitis had a higher risk of preterm delivery and preeclampsia/eclampsia.SVV are at higher risk. Claim data presented at Plenary session Vasculitis Foundation #ACR23 KenWarringtonMD

Rare Disease Advisor (@raredisease_adv) 's Twitter Profile Photo

Neurologic involvement is often reported in individuals with ANCA-associated vasculitis & can be associated with disability & chronic pain, according to findings from a retrospective analysis presented by Rula Hajj-Ali at #ACR23. Read more ➡️ brnw.ch/21wEzcX American College of Rheumatology